For presentation materials, click here.

As we near the third anniversary of the passage of the Dodd-Frank Act, many of the principle elements of the regulatory framework for OTC derivatives in the United States have been finalized. That being said, given the need for many interpretative releases and no-action or exemptive relief, and various implementation delays, market participants are still grappling with new requirements. During this webcast, we will review the status of:

• Swap Dealer and MSP registration;
• Swap data recordkeeping;
• Swap data reporting; and
• Mandatory clearing.

We also will discuss the major unfinished rulemaking areas:

• OTC margin requirements;
• Swap execution facilities;
• Extraterritoriality;
• Additional mandatory clearing designations;
• SEC Title VII implementation;
• Related areas: Volcker Rule, Lincoln Amendment; and
• Proposed legislation/future prospects.

Speakers:

• Robert J. Dilworth, Associate General Counsel, Bank of America Merrill Lynch
• David H. Kaufman, Morrison & Foerster
• Anna T. Pinedo, Morrison & Foerster
• Lucy McNulty (moderator), International Financial Law Review

NY and CA CLE credit is pending.